This compound is a fluorinated derivative of adenosine, specifically designed as an impurity reference standard for quality control in pharmaceutical manufacturing. It is characterized by a difluorinated cyclopentane core with hydroxyl and aminopurine substituents, reflecting its structural relation to adenosine.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
8-Bromo-2'-benzamido-2'-deoxy-Adenosine
pharmaceutical intermediate
(alphaR)-alpha-[[[2-(4-Nitrophenyl)ethyl]amino]methyl]benzenemethanol
pharmaceutical intermediate
4-Methoxysalicylic acid
pharmaceutical intermediate
2-amino-N-methylethane-1-sulfonamide hydrochloride
pharmaceutical intermediate
2'-O-(2-Methoxyethyl)uridine
pharmaceutical intermediate
3-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol
research compound
C-6-Cl-ddG
pharmaceutical intermediate
(1R,2S,3S,5R)-3-(6-aminopurin-9-yl)-4,4-difluoro-5-(hydroxymethyl)cyclopentane-1,2-diol
XSXKATMUCWUUFZ-JBBNEOJLSA-N
C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](C3(F)F)CO)O)O)N
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.